Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESONIA – Evaluation of Efficacy and Safety of Nebivolol in Adolescents with Arterial Hypertension
2020-003881-38Phase 3Active
- Sponsor
- Medical University of Warsaw
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of nebivolol in hypertension (HTN) (2 arms), sponsored by Medical University of Warsaw. Primary endpoint: Normalization of blood pressure at in-patient visits at week 6. Started Jan 2021; status: active.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2020-003881-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003881-38.